Halma plc (LON:HLMA) Given Average Recommendation of “Moderate Buy” by Analysts

Halma plc (LON:HLMA) has earned a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is £5,338.78.

Several research firms recently weighed in on HLMA. Shore Capital Group reaffirmed a “hold” rating on shares of Halma in a research note on Monday, April 13th. UBS Group reaffirmed a “buy” rating and issued a £47,750 price objective on shares of Halma in a research note on Friday.

Halma Stock Performance

LON:HLMA opened at GBX 4,656 on Monday. The stock’s 50-day simple moving average is GBX 4,372.69 and its 200 day simple moving average is GBX 3,928.11. The firm has a market capitalization of £17.59 billion, a PE ratio of 50.91, a price-to-earnings-growth ratio of 2.93 and a beta of 0.96. The company has a quick ratio of 1.51, a current ratio of 2.18 and a debt-to-equity ratio of 43.44. Halma has a twelve month low of GBX 2,972 and a twelve month high of GBX 4,902.

Halma Company Profile

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:

– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.